Skip to main content
SpringerLink
Log in

Cardiovascular Safety of Transdermal Nicotine Patches in Patients with Coronary Artery Disease who Try to Quit Smoking

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Abstract

Nicotine patches are commonly used by people who try to quit smoking. Because high doses of nicotine may increase heart rate and potentiate cardiac arrhythmia or ischemia, its use in patients with coronary artery disease was investigated. The objective was to assess the cardiovascular safety of nicotine patches in patients with coronary artery disease (CAD) who try to quit smoking. The study was conducted in a double-blind, placebo-controlled, randomized fashion over a 2-week period. One hundred and six patients with CAD who wished to stop smoking and were taking part in a smoking cessation program were included. Fifty-two patients received nicotine patches (Nicotinell®) and 54 received placebo patches. The cardiovascular effects of nicotine patches were assessed by repeated ambulatory ECG monitoring (AEM) and exercise testing. There were no changes in the resting heart rate and in the systolic or diastolic blood pressure between the screening and the two phases of the study in both the Nicotinell and placebo groups. Repeated 48-hour AEM revealed that there were no significant changes in the number and duration of ischemic episodes in both groups. There was no change in the frequency of atrial or ventricular arrhythmias. Exercise duration and time to 1-mm ST-segment depression increased in both groups during the double-blind treatment phase. More patients in the Nicotinell group claimed tobacco abstinence compared with the placebo group (27% vs. 13%). The use of nicotine patches did not cause aggravation of myocardial ischemia or arrhythmia in coronary patients and therefore can be used as a method to promote smoking cessation in this high-risk group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. U.S. Department of Health and Human Services. The Health Consequences of Smoking: Nicotine Addiction, A Report of the Surgeon General 1988. Rockville, MD: Office on Smoking and Health, DHSS Publication no. (CDC) 88-8406.

  2. U.S. Department of Health and Human Services. Reducing the Health Consequences of Smoking: 25 Years of Progress, A Report of the Surgeon General 1989. Rockville, MD: Office on Smoking and Health, DHSS Publication no. (CDC) 89-8411.

  3. Siegel D, Grady D, Browner WS, Hulley SB. Risk factor modification after myocardial infarction. Ann Intern Med 1988;109:213-218.

    Google Scholar 

  4. Sparrow D, Dawber TR, Colton T. The influence of cigarette smoking on prognosis after a first myocardial infarction: A report from the Framingham Study. J Chronic Dis 1978;31:425-432.

    Google Scholar 

  5. Daly LE, Mulcahy R, Graham IM, Hickey N. Long term effect on mortality of stopping smoking after unstable angina and myocardial infarction. Br Med J 1983;287:324-326.

    Google Scholar 

  6. Hedback B, Perk J. Five-year results of a comprehensive rehabilitation programme after myocardial infarction. Eur Heart J 1987;8:234-242.

    Google Scholar 

  7. AHA Consensus Panel Statement. Preventing heart attack and death in patients with coronary disease. J Am Coll Cardiol 1995;26:292-294.

    Google Scholar 

  8. Tonnesen P, Norregaard J, Simonsen K, Sawe U. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med 1991;325:311-315.

    Google Scholar 

  9. Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation. JAMA 1991;266:3133-3138.

    Google Scholar 

  10. Jorenby DE, Smith SS, Fiore MC, et al. Varying nicotine patch dose and type of smoking cessation counselling. JAMA 1995;274:1347-1352.

    Google Scholar 

  11. Dale LC, Hurt RD, Offord KP, Lawson GM, Croghan IT, Schroeder DR. High-dose nicotine patch therapy. JAMA 1995;274:1353-1358.

    Google Scholar 

  12. Kozak J, Fagerström K, Sawe U. High-dose treatment with the nicotine patch. Int J Smoking Cessation 1995;4:26-28.

    Google Scholar 

  13. Krumholz HM, Cohen BJ, Tsevat J, Pasternak RC, Weinstein MC. Cost-effectiveness of a smoking cessation program after myocardial infarction. J Am Coll Cardiol 1993; 6:1697-1702.

    Google Scholar 

  14. Joseph AM, Norman SM, Ferry LH, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996;335: 1792-1798.

    Google Scholar 

  15. Khoury Z, Comans P, Keren A, Lerer T, Gavish A, Tzivoni D. Effects of transdermal nicotine patches on ambulatory ECG monitoring findings: A double-blind study in healthy smokers. Cardiovasc Drugs Ther 1996;10:179-184.

    Google Scholar 

  16. Fagerström KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 1978;3:235-241.

    Google Scholar 

  17. Draize JH, Woodward G, Calvery HO. Methods of the study of initiation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Therap 944;82:377-419.

  18. Silagy C, Mant D, Fowler G, Lodge M. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994;343:139-142.

    Google Scholar 

  19. Fiore MC, Kenford SL, Jorenby DE, Wetter DW, Smith SS, Baker TB. Two studies of the clinical effectiveness of the nicotine patch with different counseling treatment. Chest 1994;105:524-533.

    Google Scholar 

  20. Hughes JR. Combined psychological and nicotine gum treatment for smoking: A critical review. J Subst Abuse 1991;3:337-350.

    Google Scholar 

  21. Grunberg NE, Popp KA, Bowen DJ, et al. Effects of chronic nicotine administration on insulin, glucose, epinephrine and norepinephrine. Life Sci 1988;42:161-170.

    Google Scholar 

  22. Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation: Six-month results from two multicenter controlled clinical trials. JAMA 1991;266:3133-3138.

    Google Scholar 

  23. Sachs DPL, Sawe U, Leischow SJ. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counselling. Arch Intern Med 1993;153:1881-1890.

    Google Scholar 

  24. Hurt RD, Dale LC, Fredrickson PA, et al. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up: One-year outcome and percentage of nicotine replacement. JAMA 1994;271:595-600.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Shaare Zedek Medical Center, Jerusalem, Israel

    Dan Tzivoni & Shmuel Meyler

  2. Bikur Cholim Hospital, Jerusalem, Israel

    Andre Keren MD & Zahi Khoury

  3. Hebrew University, Jerusalem, Israel

    Tuvia Lerer

  4. Ciba-Geigy Ltd., Basel, Switzerland

    Patrick Brunel

Authors
  1. Dan Tzivoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andre Keren MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shmuel Meyler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zahi Khoury
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tuvia Lerer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Patrick Brunel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tzivoni, D., Keren, A., Meyler, S. et al. Cardiovascular Safety of Transdermal Nicotine Patches in Patients with Coronary Artery Disease who Try to Quit Smoking. Cardiovasc Drugs Ther 12, 239–244 (1998). https://doi.org/10.1023/A:1007757530765

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007757530765

Search

Navigation